Cargando…
Pilot Study of a Clinical Pathway Implementation in Rectal Cancer
BACKGROUND: Rectal cancer is a highly prevalent disease which needs a multidisciplinary approach to be treated. The absence of specific protocols implies a significant and unjustifiable variability among the different professionals involved in this disease. The purpose is to develop a clinical pathw...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998871/ https://www.ncbi.nlm.nih.gov/pubmed/21151842 http://dx.doi.org/10.4137/CMO.S4651 |
_version_ | 1782193407754502144 |
---|---|
author | Uña, Esther López-Lara, Francisco |
author_facet | Uña, Esther López-Lara, Francisco |
author_sort | Uña, Esther |
collection | PubMed |
description | BACKGROUND: Rectal cancer is a highly prevalent disease which needs a multidisciplinary approach to be treated. The absence of specific protocols implies a significant and unjustifiable variability among the different professionals involved in this disease. The purpose is to develop a clinical pathway based on the analysis process and aims to reduce this variability and to reduce unnecessary costs. METHODS: We created a multidisciplinary team with contributors from every clinical area involved in the diagnosis and treatment in this disease. We held periodic meetings to agree on a protocol based on the best available clinical practice guidelines. Once we had agreed on the protocol, we implemented its use as a standard in our institution. Every patient older than 18 years who was diagnosed with rectal cancer was considered a candidate to be treated via the pathway. RESULTS: We evaluated 48 patients during the course of this study. Every parameter measured was improved after the implementation of the pathway, except the proportion of patients with 12 nodes or more analysed. The perception that our patients had about this project was very good. CONCLUSIONS: Clinical pathways are needed to improve the quality of health care. This kind of project helps reduce hospital costs and optimizes the use of limited resources. On the other hand, unexplained variability is also reduced, with consequent benefits for the patients. |
format | Text |
id | pubmed-2998871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-29988712010-12-10 Pilot Study of a Clinical Pathway Implementation in Rectal Cancer Uña, Esther López-Lara, Francisco Clin Med Insights Oncol Original Research BACKGROUND: Rectal cancer is a highly prevalent disease which needs a multidisciplinary approach to be treated. The absence of specific protocols implies a significant and unjustifiable variability among the different professionals involved in this disease. The purpose is to develop a clinical pathway based on the analysis process and aims to reduce this variability and to reduce unnecessary costs. METHODS: We created a multidisciplinary team with contributors from every clinical area involved in the diagnosis and treatment in this disease. We held periodic meetings to agree on a protocol based on the best available clinical practice guidelines. Once we had agreed on the protocol, we implemented its use as a standard in our institution. Every patient older than 18 years who was diagnosed with rectal cancer was considered a candidate to be treated via the pathway. RESULTS: We evaluated 48 patients during the course of this study. Every parameter measured was improved after the implementation of the pathway, except the proportion of patients with 12 nodes or more analysed. The perception that our patients had about this project was very good. CONCLUSIONS: Clinical pathways are needed to improve the quality of health care. This kind of project helps reduce hospital costs and optimizes the use of limited resources. On the other hand, unexplained variability is also reduced, with consequent benefits for the patients. Libertas Academica 2010-10-12 /pmc/articles/PMC2998871/ /pubmed/21151842 http://dx.doi.org/10.4137/CMO.S4651 Text en © 2010 the author(s), publisher and licensee Libertas Academica Ltd. This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited. |
spellingShingle | Original Research Uña, Esther López-Lara, Francisco Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title | Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title_full | Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title_fullStr | Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title_full_unstemmed | Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title_short | Pilot Study of a Clinical Pathway Implementation in Rectal Cancer |
title_sort | pilot study of a clinical pathway implementation in rectal cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998871/ https://www.ncbi.nlm.nih.gov/pubmed/21151842 http://dx.doi.org/10.4137/CMO.S4651 |
work_keys_str_mv | AT unaesther pilotstudyofaclinicalpathwayimplementationinrectalcancer AT lopezlarafrancisco pilotstudyofaclinicalpathwayimplementationinrectalcancer |